{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T11:18:14Z","timestamp":1717759094210},"reference-count":28,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/or.2014.3622","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T04:56:04Z","timestamp":1416891364000},"page":"893-898","source":"Crossref","is-referenced-by-count":4,"title":["Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A"],"prefix":"10.3892","volume":"33","author":[{"given":"XIAOLI","family":"MA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUA","family":"DUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QINGQING","family":"MO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENGJUAN","family":"SUN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DING","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIANDONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"key20180107213255_b1-or-33-02-0893","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107213255_b2-or-33-02-0893","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"key20180107213255_b3-or-33-02-0893","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.2012.665366","article-title":"Recent advances in drug delivery strategies for treatment of ovarian cancer","volume":"9","author":"Zahedi","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"key20180107213255_b4-or-33-02-0893","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1073\/pnas.1305472110","article-title":"A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis","volume":"110","author":"Vecchione","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107213255_b5-or-33-02-0893","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"2","author":"West","year":"2014","journal-title":"J Clin Invest"},{"key":"key20180107213255_b6-or-33-02-0893","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CAD.0000000000000040","article-title":"Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors","volume":"25","author":"Slingerland","year":"2014","journal-title":"Anticancer Drugs"},{"key":"key20180107213255_b7-or-33-02-0893","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd4154","article-title":"Histone lysine demethylases as targets for anticancer therapy","volume":"12","author":"H\u00f8jfeldt","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107213255_b8-or-33-02-0893","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/14737140.7.4.583","article-title":"Development of histone deacetylase inhibitors for cancer treatment","volume":"7","author":"Marchion","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107213255_b9-or-33-02-0893","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"key20180107213255_b10-or-33-02-0893","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.16.5.659","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"16","author":"Rasheed","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180107213255_b11-or-33-02-0893","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-08-2999","article-title":"A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer","volume":"15","author":"Fakih","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107213255_b12-or-33-02-0893","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/1535-7163.MCT-08-0772","article-title":"Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach","volume":"8","author":"Ma","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107213255_b13-or-33-02-0893","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature02545","article-title":"Zinc transporter LIV-1 controls epithelial-mesenchymal transition in zebrafish gastrula organizer","volume":"429","author":"Yamashita","year":"2004","journal-title":"Nature"},{"key":"key20180107213255_b14-or-33-02-0893","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.21235","article-title":"Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients","volume":"117","author":"Kasper","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107213255_b15-or-33-02-0893","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-09-3174","article-title":"Synergistic killing effect between vorinostat and target of CD146 in malignant cells","volume":"16","author":"Ma","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107213255_b16-or-33-02-0893","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/01635581.2014.851713","article-title":"Zinc status alters growth and oxidative stress responses in rat hepatoma cells","volume":"66","author":"Sankavaram","year":"2014","journal-title":"Nutr Cancer"},{"key":"key20180107213255_b17-or-33-02-0893","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1756-0500-7-84","article-title":"Effects of zinc supplementation and zinc chelation on in vitro \u03b2-cell function in INS-1E cells","volume":"7","author":"Nygaard","year":"2014","journal-title":"BMC Res Notes"},{"key":"key20180107213255_b18-or-33-02-0893","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12011-014-9922-x","article-title":"Zinc modulates high glucose-induced apoptosis by suppressing oxidative stress in renal tubular epithelial cells","volume":"158","author":"Zhang","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"key20180107213255_b19-or-33-02-0893","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1389450033491082","article-title":"Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate","volume":"4","author":"Chimienti","year":"2003","journal-title":"Curr Drug Targets"},{"key":"key20180107213255_b20-or-33-02-0893","first-page":"62146","article-title":"Ovarian cancer","volume":"13","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"key20180107213255_b21-or-33-02-0893","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.7810","article-title":"Current approaches and challenges in managing and monitoring treatment response in ovarian cancer","volume":"5","author":"Marcus","year":"2014","journal-title":"J Cancer"},{"key":"key20180107213255_b22-or-33-02-0893","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0005-2736(03)00048-8","article-title":"The LZT proteins; the LIV-1 subfamily of zinc transporters","volume":"1611","author":"Taylor","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"key20180107213255_b23-or-33-02-0893","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/15216540050033087","article-title":"LIV-1 breast cancer protein belongs to a new family of histidine-rich membrane proteins with potential to control intracellular Zn2+ homeostasis","volume":"49","author":"Taylor","year":"2000","journal-title":"IUBMB Life"},{"key":"key20180107213255_b24-or-33-02-0893","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj20030478","article-title":"Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters","volume":"375","author":"Taylor","year":"2003","journal-title":"Biochem J"},{"key":"key20180107213255_b25-or-33-02-0893","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/hsz-2013-0128","article-title":"Targeting caspases in cancer therapeutics","volume":"394","author":"Hensley","year":"2013","journal-title":"Biol Chem"},{"key":"key20180107213255_b26-or-33-02-0893","first-page":"146","article-title":"Programmed cell death and apoptosis-where it came from and where it is going: from Elie Metchnikoff to the control of caspases","volume":"34","author":"Maghsoudi","year":"2012","journal-title":"Exp Oncol"},{"key":"key20180107213255_b27-or-33-02-0893","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-010-0709-x","article-title":"Role of Bcl-2 family proteins and caspases in the regulation of apoptosis","volume":"351","author":"Ola","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"key20180107213255_b28-or-33-02-0893","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin Ther Targets"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3622\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:33:11Z","timestamp":1515342791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,25]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/or.2014.3622"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3622","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]}}}